From 01 August 2016
Cadila Healthcare announced that Company's US based 100% subsidiary company Zydus Pharmaceuticals (USA) Inc. (Zydus) will begin informing on 12 July 2016 its customers that Zydus will start selling an authorized generic of Asacol HD (mesalamine delayed - release tablets 800 mg) in the United States commencing on 01 August 2016.Powered by Capital Market - Live News